VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,299,319 | -18.1% | 3,550,074 | +19.9% | 0.02% | -15.0% |
Q2 2023 | $48,006,904 | +21013.8% | 2,961,561 | +21586.9% | 0.02% | – |
Q1 2023 | $227,372 | -4.9% | 13,656 | -82.8% | 0.00% | – |
Q1 2022 | $239,000 | -34.5% | 79,600 | +0.3% | 0.00% | – |
Q4 2021 | $365,000 | -26.9% | 79,400 | 0.0% | 0.00% | – |
Q3 2021 | $499,000 | +4.8% | 79,400 | 0.0% | 0.00% | – |
Q2 2021 | $476,000 | +15.8% | 79,400 | +22.2% | 0.00% | – |
Q1 2021 | $411,000 | -5.5% | 65,000 | -15.8% | 0.00% | – |
Q4 2020 | $435,000 | -3.1% | 77,200 | 0.0% | 0.00% | – |
Q3 2020 | $449,000 | -21.9% | 77,200 | -3.1% | 0.00% | – |
Q2 2020 | $575,000 | +47.1% | 79,700 | -4.7% | 0.00% | – |
Q1 2020 | $391,000 | -30.7% | 83,600 | +18.9% | 0.00% | – |
Q4 2019 | $564,000 | +16.5% | 70,300 | 0.0% | 0.00% | – |
Q3 2019 | $484,000 | -17.0% | 70,300 | 0.0% | 0.00% | – |
Q2 2019 | $583,000 | -16.6% | 70,300 | 0.0% | 0.00% | – |
Q1 2019 | $699,000 | +37.9% | 70,300 | +6.0% | 0.00% | – |
Q4 2018 | $507,000 | -54.4% | 66,300 | +3.9% | 0.00% | -100.0% |
Q3 2018 | $1,111,000 | +83.6% | 63,800 | 0.0% | 0.00% | – |
Q2 2018 | $605,000 | – | 63,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |